* U.S. FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow
The post BRIEF-U.S. FDA approves first treatment for rare disease in patients who receive stem cell transplant from blood or bone marrow appeared first on NASDAQ.